15Apr 2025
Real-World Impact of COVID-19 Drugs Assessed Retrospectively

Real-World Impact of COVID-19 Drugs Assessed Retrospectively

In a large retrospective study from 2020–2022, most COVID-19 treatments showed no clear benefit in real-life settings. Outpatient corticosteroid use increased hospitalizations. Among ICU patients, corticosteroids lowered intrahospital mortality (OR: 0.73). Other drugs, including remdesivir and tocilizumab, were associated with increased ICU admissions and longer stays. These findings underscore the need to reevaluate treatment strategies outside of clinical trials.

  • #pulmonology

Like

Save

Share